Real-World Treatment Patterns and Vision Outcomes with Ranibizumab for Diabetic Macular Edema.

Intravitreal ranibizumab for diabetic macular edema was effective in a real-world clinical setting, with most eyes gaining or maintaining vision. Compared with randomized prospective clinical trials, patients received less frequent injections and achieved lower vision gains.